Matches in Library of Congress for { <http://lccn.loc.gov/2008940836> ?p ?o. }
Showing items 1 to 27 of
27
with 100 items per page.
- 2008940836 contributor B11390112.
- 2008940836 created "c2009.".
- 2008940836 date "2009".
- 2008940836 date "c2009.".
- 2008940836 dateCopyrighted "c2009.".
- 2008940836 description "Includes bibliographical references and index.".
- 2008940836 description "Targeted therapy for metastatic renal call carcinoma: overview -- Molecular genetics in inherited renal cell carcinoma: identification of targets in the hereditary syndromes -- Molecular targets in renal tumors: pathologic assessment -- Interferons and interleukin-2: molecular basis of activity and therapeutic results -- The molecular biology of kidney cancer and its clinical translation into treatment strategies -- VEGF: biologic aspects and clinical approaches -- VEGF and PDGF receptors: biologic relevance and clinical approaches to inhibition -- Sunitinib and axitinib in renal cell carcinoma -- Sorafenib in renal cell carcinoma -- Additional tyrosine kinase inhibitors in renal cell carcinoma -- Integrin [alpha]5[beta]1 as a novel therapeutic target in renal cancer -- Carbonic anhydrase IX: biology and clinical approaches -- Monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma: biological and clinical studies -- Chemokines in renal cell carcinoma: implications for tumor angiogenesis and metastasis -- P13K/Akt/mTOR pathway: a growth and proliferation pathway -- EGFR and HER2: relevance in renal cell carcinoma -- Proteasome-NF[kappa]B signaling pathway: relevance in RCC -- The role of hepatocyte growth factor pathway signaling in renal cell carcinoma -- Smac/DIABLO: a proapoptotic molecular target in renal cell cancer -- EphA2: a novel target in renal cell carcinoma -- Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma -- The role of gangliosides in renal cell carcinoma -- Tumour necrosis factor: misnomer and therapeutic target -- Molecular markers for predicting prognosis of renal cell carcinoma -- Adjuvant therapy for renal cell carcinoma: targeted approaches.".
- 2008940836 extent "xvii, 507 p. :".
- 2008940836 identifier "1588297373 (alk. paper)".
- 2008940836 identifier "1597453323 (e-ISBN)".
- 2008940836 identifier "9781588297372 (alk. paper)".
- 2008940836 identifier "9781597453325 (e-ISBN)".
- 2008940836 issued "2009".
- 2008940836 issued "c2009.".
- 2008940836 language "eng".
- 2008940836 publisher "New York : Humana Press,".
- 2008940836 subject "2009 D-966".
- 2008940836 subject "616.99/461 22".
- 2008940836 subject "Carcinoma, Renal Cell.".
- 2008940836 subject "Hypernephrom. swd".
- 2008940836 subject "Kidney Neoplasms.".
- 2008940836 subject "RC280.K5 R466 2009".
- 2008940836 subject "Renal cell carcinoma.".
- 2008940836 subject "WJ 358 R39365 2009".
- 2008940836 tableOfContents "Targeted therapy for metastatic renal call carcinoma: overview -- Molecular genetics in inherited renal cell carcinoma: identification of targets in the hereditary syndromes -- Molecular targets in renal tumors: pathologic assessment -- Interferons and interleukin-2: molecular basis of activity and therapeutic results -- The molecular biology of kidney cancer and its clinical translation into treatment strategies -- VEGF: biologic aspects and clinical approaches -- VEGF and PDGF receptors: biologic relevance and clinical approaches to inhibition -- Sunitinib and axitinib in renal cell carcinoma -- Sorafenib in renal cell carcinoma -- Additional tyrosine kinase inhibitors in renal cell carcinoma -- Integrin [alpha]5[beta]1 as a novel therapeutic target in renal cancer -- Carbonic anhydrase IX: biology and clinical approaches -- Monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma: biological and clinical studies -- Chemokines in renal cell carcinoma: implications for tumor angiogenesis and metastasis -- P13K/Akt/mTOR pathway: a growth and proliferation pathway -- EGFR and HER2: relevance in renal cell carcinoma -- Proteasome-NF[kappa]B signaling pathway: relevance in RCC -- The role of hepatocyte growth factor pathway signaling in renal cell carcinoma -- Smac/DIABLO: a proapoptotic molecular target in renal cell cancer -- EphA2: a novel target in renal cell carcinoma -- Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma -- The role of gangliosides in renal cell carcinoma -- Tumour necrosis factor: misnomer and therapeutic target -- Molecular markers for predicting prognosis of renal cell carcinoma -- Adjuvant therapy for renal cell carcinoma: targeted approaches.".
- 2008940836 title "Renal cell carcinoma : molecular targets and clinical applications / Ronald M. Bukowski, Robert A. Figlin, Robert J. Motzer, editors.".
- 2008940836 type "text".